United States · FDA National Drug Code directory
Cephalexin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 55289-057_4d51b7fa-92f9-1fdd-e063-6394a90af262
- Product NDC
- 55289-057
- Form
- CAPSULE
- Composition / generic term
- Cephalexin
- Labeler
- PD-Rx Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 19900930
- Source listing expiry
- 20271231
Source-listed ingredients
- CEPHALEXIN — 250 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 6 CAPSULE in 1 BOTTLE, PLASTIC (55289-057-06) · 55289-057-06
- 15 CAPSULE in 1 BOTTLE, PLASTIC (55289-057-15) · 55289-057-15
- 20 CAPSULE in 1 BOTTLE, PLASTIC (55289-057-20) · 55289-057-20
- 28 CAPSULE in 1 BOTTLE, PLASTIC (55289-057-28) · 55289-057-28
- 30 CAPSULE in 1 BOTTLE, PLASTIC (55289-057-30) · 55289-057-30
- 40 CAPSULE in 1 BOTTLE, PLASTIC (55289-057-40) · 55289-057-40
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →